# Study to Evaluate Imatinib in Desmoid Tumors

> **NCT01137916** · PHASE2 · COMPLETED · sponsor: **Heidelberg University** · enrollment: 39 (actual)

## Conditions studied

- Aggressive Fibromatosis
- Desmoid Tumor

## Interventions

- **DRUG:** Imatinib

## Key facts

- **NCT ID:** NCT01137916
- **Lead sponsor:** Heidelberg University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2017-05-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01137916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01137916, "Study to Evaluate Imatinib in Desmoid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01137916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*